Skip to content

spinal Anaesthesia for breast surgeries.

to compare the efficacy of segmental spinal anaesthesia with general anaesthesia for breast surgeries.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050289
Enrollment
60
Registered
2023-03-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C50-C50- Malignant neoplasms of breast Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Thoracic segmental spinal anaesthesia for breast surgeries at thoracic t4-t6 vertebrae.: spinal anaesthesia using isobaric ropivacaine 0.75% in t4 to t6 interspace will be given.cases w
neostigmine + glycopyrrolate. Control Intervention2: General Anaesthesia for patients posted for elective breast surgeries.: general anethesia with premedication: glyco 0.2mg,midazolam 1mg, ondensetro

Sponsors

Dr Neha Panse
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients posted for simple lumpectomies or breast malignancy surgeries. ASA I,II,III

Exclusion criteria

Exclusion criteria: NO concent coagulopathies ASA IV patients

Design outcomes

Primary

MeasureTime frame
better hemodynamics, early ambulation and discharge time with segmental spinal than general anaesthesia Timepoint: before spinal anaesthesia 5 mins after spinal anaesthesia 1 hour after spinal anaesthesai shifting to recovery discharge time

Secondary

MeasureTime frame
better VAS score, Former’s score (surgical field quality), intra-operative blood loss, side effects (PONV, dizziness, tingling, urinary retention,) oral feeds.Timepoint: before spinal anaesthesia 5 mins after spinal anaesthesia 1 hour after spinal anaesthesai shifting to recovery discharge time

Countries

India

Contacts

Public ContactDr Neha Panse

Smt. kashibai Navale medical college and general hospital.

drnehaghule@gmail.com9689495891

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026